Low-passage tumor cell lines are versatile tools to study tumor cell biology. one cell collection was resistant. The multikinase inhibitor regorafenib inhibited proliferation of all CRC lines with related efficiency and independent of the presence or absence of mutations. Regorafenib action was associated with broad-range inhibitory effects at the level of gene manifestation but not… Continue reading Low-passage tumor cell lines are versatile tools to study tumor cell